Advertisement minSURG establishes new international division - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

minSURG establishes new international division

minSURG, producers of the TruFUSE percutaneous facet stabilization procedure, has announced the creation of minSURG International, Incorporated.

The international division has been established in response to global demand for the TruFUSE procedure and products.

minSURG’s TruFUSE procedure uses specially designed human bone dowels to stop facet joints from moving, which is intended to eliminate or reduce back pain caused by a variety of reasons. TruFUSE is also used to supplement other back surgeries when more invasive or destructive means are not required.

Jim Doulgeris, CEO of minSURG, said: “Distributors from Canada, Brazil, Germany, Greece, South Korea, Netherlands, Singapore, Taiwan, Turkey and Japan have expressed strong interest in providing the benefits of our minimally invasive and percutaneous spinal fusion to their populations suffering from debilitating back pain. Sales to Turkey and Greece have already been initiated.”